Trial intelligence / Profile preview

Raloxifene add-on therapy in acromegaly patients on long-term octreotide

2006-004989-14Phase 4Completed

Sponsor
The Christie
Start
Oct 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of raloxifene in acromegaly, sponsored by The Christie. Primary endpoint: Change in serum IGF-I levels. Started Oct 2006; status: completed.

02

Drugs

raloxifene
03

Conditions

acromegaly

Beyond the preview

Go deeper on 2006-004989-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004989-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call